Enovis 

R$38.72
21
+R$0+0% Thursday 19:35

Statistics

Day High
38.72
Day Low
38.72
52W High
48.49
52W Low
38.72
Volume
0
Avg. Volume
1,811
Mkt Cap
2.21B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26FebExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
0.59
0.72
0.85
0.98
Expected EPS
0.840481
Actual EPS
N/A

Financials

-40.73%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
24.77BRevenue
-10.09BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow E2NO34.SA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew competes directly with Enovis in the orthopedics segment, offering similar products for joint replacement and repair.
Stryker
SYK
Mkt Cap136.19B
Stryker is a major competitor in the medical technology field, particularly in orthopedics, surgical equipment, and neurotechnology, directly competing with Enovis' product lines.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. is a direct competitor in the orthopedic device market, offering a wide range of products for joint reconstruction, similar to Enovis.
Medtronic
MDT
Mkt Cap116.33B
Medtronic competes with Enovis in multiple areas, including surgical products and patient monitoring systems, making it a broad competitor.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical devices segment, competes across several areas with Enovis, including surgical products and orthopedics.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation offers products in various medical fields that overlap with Enovis' offerings, including surgical and orthopedic devices.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories competes with Enovis through its range of medical devices, including vascular and neuromodulation devices, overlapping with Enovis' market.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical, Inc. competes in the spine orthopedic devices market, offering innovative solutions that rival Enovis' spine-focused products.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences Holdings Corporation offers products in orthopedics and tissue technologies, competing with Enovis in the surgical and orthopedic device market.

About

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Show more...
CEO
Mr. Mitchell P. Rales
Employees
16200
Country
United States
ISIN
BRE2NOBDR001

Listings

0 Comments

Share your thoughts

FAQ

What is Enovis stock price today?
The current price of E2NO34.SA is R$38.72 BRL — it has increased by +0% in the past 24 hours. Watch Enovis stock price performance more closely on the chart.
What is Enovis stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Enovis stocks are traded under the ticker E2NO34.SA.
What is Enovis market cap?
Today Enovis has the market capitalization of 2.21B
When is the next Enovis earnings date?
Enovis is going to release the next earnings report on February 26, 2026.
What were Enovis earnings last quarter?
E2NO34.SA earnings for the last quarter are 4.01 BRL per share, whereas the estimation was 3.47 BRL resulting in a +15.57% surprise. The estimated earnings for the next quarter are N/A BRL per share.
What is Enovis revenue for the last year?
Enovis revenue for the last year amounts to 24.77B BRL.
What is Enovis net income for the last year?
E2NO34.SA net income for the last year is -10.09B BRL.
How many employees does Enovis have?
As of February 10, 2026, the company has 16,200 employees.
In which sector is Enovis located?
Enovis operates in the Other sector.
When did Enovis complete a stock split?
Enovis has not had any recent stock splits.
Where is Enovis headquartered?
Enovis is headquartered in Wilmington, United States.